Deborah Morosini
Director/Board Member chez National Comprehensive Cancer Network Foundation
Profil
Deborah Morosini a fondé AstraZeneca Pharmaceuticals LP. Elle est Chief Clinical Affairs Officer & Executive VP chez Prelude Therapeutics, Inc. Elle est également membre du conseil d'administration de la National Comprehensive Cancer Network Foundation et de Clinwiki. Dans le passé, elle a été vice-présidente des affaires cliniques et de l'engagement des patients chez Loxo Oncology, Inc. et vice-présidente des affaires cliniques et de l'engagement des patients chez Foundation Medicine, Inc. et directrice de la pathologie chez Ardais Corp. Deborah Morosini a obtenu un diplôme de premier cycle au Mount Holyoke College, un diplôme d'études supérieures à l'école de travail social de l'université de New York et un doctorat à l'école de médecine de l'université de Boston.
Postes actifs de Deborah Morosini
| Sociétés | Poste | Début |
|---|---|---|
| National Comprehensive Cancer Network Foundation | Director/Board Member | - |
| Clinwiki | Director/Board Member | - |
Anciens postes connus de Deborah Morosini
| Sociétés | Poste | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | 06/04/2022 |
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 01/04/2019 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/04/2016 |
Ardais Corp.
 Ardais Corp. Information Technology ServicesTechnology Services Ardais Corp. provides web-based software solutions for the healthcare industry. The company is based in Lexington, MA. The company was founded by Eric B. Gordon, Alan J. Buckler, Martin Ferguson, Heidi R. Wyle. Ardais was acquired by HealthCare IT, Inc. on December 31, 2006. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Founder | - |
Formation de Deborah Morosini
| Mount Holyoke College | Undergraduate Degree |
| New York University School of Social Work | Graduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Entreprise privées | 6 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Ardais Corp.
Ardais Corp. Information Technology ServicesTechnology Services Ardais Corp. provides web-based software solutions for the healthcare industry. The company is based in Lexington, MA. The company was founded by Eric B. Gordon, Alan J. Buckler, Martin Ferguson, Heidi R. Wyle. Ardais was acquired by HealthCare IT, Inc. on December 31, 2006. | Technology Services |
| National Comprehensive Cancer Network Foundation | |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
| Clinwiki |
